Category: Drug Commercialization

Integrated obesity evidence strategy: Designing trials beyond weight loss

From submission to surveillance: rethinking market entry as a lifecycle strategy

Beyond trial volume: What China’s clinical trial data signal for global development planning

From “transaction expansion” to “certainty-driven expansion”: How can innovative Chinese drugs turn promising assets into global value?

REMS: To outsource or not to outsource?

Registries for Regulatory Decision-Making: Comparing EMA and FDA Guidance on Real-World Evidence

Five Key Decision Points That Set You Up for Commercial Success

Early Engagement Strategies to Set Cell & Gene Therapies Up for Success

Why Payer Perspectives Should Be On Your Radar Now–Even If Your Launch Is Years Away